Skip to content
2000
image of RAAS Overactivation and Mitochondrial Damage Signaling as Key Players in Lethal COVID-19

Abstract

Coronavirus disease 2019 (COVID-19), which led to a global pandemic causing millions of deaths, is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). While previous research on COVID-19 has primarily utilized nasal swabs and blood samples, these do not provide comprehensive insights into all the organ systems affected by the infection. A recent study by Topper addressed this gap by analyzing both nasal samples and autopsy tissues from SARS-CoV-2-infected individuals. Their findings highlight a significant role of mitochondrial damage pathways and RAAS overactivation in contributing to the severity of SARS- CoV-2 infections. Importantly, targeting mitochondrial dysfunction and RAAS overactivation pathways may offer promising and specific druggable targets for treating COVID-19 patients.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/0113894501387212250525161808
2025-05-27
2025-09-14
Loading full text...

Full text loading...

References

  1. Jha P. Brown P.E. Ansumana R. Counting the global COVID-19 dead. Lancet 2022 399 10339 1937 1938 10.1016/S0140‑6736(22)00845‑5 35533709
    [Google Scholar]
  2. Ng D.L. Granados A.C. Santos Y.A. Servellita V. Goldgof G.M. Meydan C. Sotomayor-Gonzalez A. Levine A.G. Balcerek J. Han L.M. Akagi N. Truong K. Neumann N.M. Nguyen D.N. Bapat S.P. Cheng J. Martin C.S.S. Federman S. Foox J. Gopez A. Li T. Chan R. Chu C.S. Wabl C.A. Gliwa A.S. Reyes K. Pan C.Y. Guevara H. Wadford D. Miller S. Mason C.E. Chiu C.Y. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood. Sci. Adv. 2021 7 6 eabe5984 10.1126/sciadv.abe5984 33536218
    [Google Scholar]
  3. Lamers M.M. Haagmans B.L. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022 20 270 284 10.1038/s41579‑022‑00713‑0
    [Google Scholar]
  4. Hu B. Huang S. Yin L. The cytokine storm and COVID-19. J. Med. Virol. 2021 93 1 250 256 10.1002/jmv.26232 32592501
    [Google Scholar]
  5. Zanza C. Romenskaya T. Manetti A. Franceschi F. La Russa R. Bertozzi G. Maiese A. Savioli G. Volonnino G. Longhitano Y. Cytokine storm in COVID-19: Immunopathogenesis and therapy. Medicina 2022 58 2 144 10.3390/medicina58020144 35208467
    [Google Scholar]
  6. Tang L. Yin Z. Hu Y. Mei H. Controlling cytokine storm is vital in COVID-19. Front. Immunol. 2020 11 570993 10.3389/fimmu.2020.570993 33329533
    [Google Scholar]
  7. Topper M.J. Guarnieri J.W. Haltom J.A. Chadburn A. Cope H. Frere J. An J. Borczuk A. Sinha S. Kim J. Park J. Butler D. Meydan C. Foox J. Bram Y. Richard S.A. Epsi N.J. Agan B. Chenoweth J.G. Simons M.P. Tribble D. Burgess T. Dalgard C. Heise M.T. Moorman N.J. Baxter V.K. Madden E.A. Taft-Benz S.A. Anderson E.J. Sanders W.A. Dickmander R.J. Beigel K. Widjaja G.A. Janssen K.A. Lie T. Murdock D.G. Angelin A. Soto Albrecht Y.E. Olali A.Z. Cen Z. Dybas J. Priebe W. Emmett M.R. Best S.M. Kelsey Johnson M. Trovao N.S. Clark K.B. Zaksas V. Meller R. Grabham P. Schisler J.C. Moraes-Vieira P.M. Pollett S. Mason C.E. Syrkin Wurtele E. Taylor D. Schwartz R.E. Beheshti A. Wallace D.C. Baylin S.B. Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes. Proc. Natl. Acad. Sci. USA 2024 121 49 e2401968121 10.1073/pnas.2401968121 39602262
    [Google Scholar]
  8. Wilczynski S.A. Wenceslau C.F. McCarthy C.G. Webb R.C. A cytokine/bradykinin storm comparison: What is the relationship between hypertension and COVID-19? Am. J. Hypertens. 2021 34 4 304 306 10.1093/ajh/hpaa217 33877321
    [Google Scholar]
  9. de las Heras N. Martín Giménez V.M. Ferder L. Manucha W. Lahera V. Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: Therapeutic effects of vitamin D. Antioxidants 2020 9 9 897 10.3390/antiox9090897 32967329
    [Google Scholar]
  10. Busse P.J. Christiansen S.C. Hereditary Angioedema. N. Engl. J. Med. 2020 382 12 1136 1148 10.1056/NEJMra1808012 32187470
    [Google Scholar]
  11. Duarte M. Pelorosso F. Nicolosi L.N. Victoria Salgado M. Vetulli H. Aquieri A. Azzato F. Castro M. Coyle J. Davolos I. Criado I.F. Gregori R. Mastrodonato P. Rubio M.C. Sarquis S. Wahlmann F. Rothlin R.P. Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial. EClinicalMedicine 2021 37 100962 10.1016/j.eclinm.2021.100962 34189447
    [Google Scholar]
  12. Ni W. Yang X. Yang D. Bao J. Li R. Xiao Y. Hou C. Wang H. Liu J. Yang D. Xu Y. Cao Z. Gao Z. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 2020 24 1 422 10.1186/s13054‑020‑03120‑0 32660650
    [Google Scholar]
  13. Bourgonje A.R. Abdulle A.E. Timens W. Hillebrands J.L. Navis G.J. Gordijn S.J. Bolling M.C. Dijkstra G. Voors A.A. Osterhaus A.D.M.E. van der Voort P.H.J. Mulder D.J. van Goor H. Angiotensin-converting enzyme 2 ( ACE2 ), SARS-CoV -2 and the pathophysiology of coronavirus disease 2019 ( COVID -19). J. Pathol. 2020 251 3 228 248 10.1002/path.5471 32418199
    [Google Scholar]
  14. Qudus M.S. Tian M. Sirajuddin S. Liu S. Afaq U. Wali M. Liu J. Pan P. Luo Z. Zhang Q. Yang G. Wan P. Li Y. Wu J. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection. J. Med. Virol. 2023 95 4 e28751 10.1002/jmv.28751 37185833
    [Google Scholar]
  15. Ramos S.G. Rattis B.A.C. Ottaviani G. Celes M.R.N. Dias E.P. ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients. Am. J. Pathol. 2021 191 7 1154 1164 10.1016/j.ajpath.2021.04.010 33964216
    [Google Scholar]
  16. Wilkerson R.G. Moellman J.J. Hereditary angioedema. Emerg Med Clin North Am 2022 40 1 99 118 10.1016/j.emc.2021.09.002 34782094
    [Google Scholar]
  17. Shou S. Liu M. Yang Y. Kang N. Song Y. Tan D. Liu N. Wang F. Liu J. Xie Y. Animal models for COVID-19: Hamsters, mouse, ferret, mink, tree shrew, and non-human primates. Front. Microbiol. 2021 12 626553 10.3389/fmicb.2021.626553 34531831
    [Google Scholar]
  18. Wang X. Chen Z. Nie D. Zeng X. Zhong M. Liu X. Zhong S. Wang L. Liao Z. Chen C. Li Y. Zeng C. CASP1 is a target for combination therapy in pancreatic cancer. Eur. J. Pharmacol. 2023 961 176175 10.1016/j.ejphar.2023.176175 37949157
    [Google Scholar]
  19. Liu X. Yang N. Tang J. Liu S. Luo D. Duan Q. Wang X. Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus. Virus Res. 2014 185 64 71 10.1016/j.virusres.2014.03.010 24662240
    [Google Scholar]
  20. Yang P. Gu H. Zhao Z. Wang W. Cao B. Lai C. Yang X. Zhang L. Duan Y. Zhang S. Chen W. Zhen W. Cai M. Penninger J.M. Jiang C. Wang X. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci. Rep. 2014 4 1 7027 10.1038/srep07027 25391767
    [Google Scholar]
  21. Banu N. Panikar S.S. Leal L.R. Leal A.R. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome: Therapeutic implications. Life Sci. 2020 256 117905 10.1016/j.lfs.2020.117905 32504757
    [Google Scholar]
  22. Hampshire A. Azor A. Atchison C. Trender W. Hellyer P.J. Giunchiglia V. Husain M. Cooke G.S. Cooper E. Lound A. Donnelly C.A. Chadeau-Hyam M. Ward H. Elliott P. Cognition and memory after Covid-19 in a large community sample. N. Engl. J. Med. 2024 390 9 806 818 10.1056/NEJMoa2311330 38416429
    [Google Scholar]
  23. Noonong K. Chatatikun M. Surinkaew S. Kotepui M. Hossain R. Bunluepuech K. Noothong C. Tedasen A. Klangbud W.K. Imai M. Kawakami F. Kubo M. Kitagawa Y. Ichikawa H. Kanekura T. Sukati S. Somsak V. Udomwech L. Ichikawa T. Nissapatorn V. Tangpong J. Indo H.P. Majima H.J. Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis. Front. Immunol. 2023 14 1275001 10.3389/fimmu.2023.1275001 38187378
    [Google Scholar]
/content/journals/cdt/10.2174/0113894501387212250525161808
Loading
/content/journals/cdt/10.2174/0113894501387212250525161808
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test